EUROAPI and BianoGMP, a contract development and manufacturing organization (CDMO) with expertise in oligonucleotides, signed a share purchase and transfer agreement under which EUROAPI will acquire BianoGMP in a €10 million transaction. The acquisition aims to increase Biano’s capacity to address larger scale and more complex projects. Biano, based in Germany, is an oligonucleotide CDMO player focused on small-scale, early-stage, complex and customized projects, with a diversified client bas...